Behavioral Health Business May 1, 2024
Laura Lovett

Prescriptions for buprenorphine, a medication-assisted-treatment (MAT) used to treat opioid use disorder, are increasing at community health centers (CHCs).

New research published in JAMA revealed that between 2016 and 2021, the percentage of patients receiving buprenorphine increased from 0.5% to 1.4%. Additionally, the percentage of clinicians prescribing buprenorphine increased from 8.9% to 37.5% during that time frame.

Researchers analyzed electronic health record data from health IT nonprofit OCHIN’s network of CHCs. The analysis included 166 clinics and contributions from 2186 unique clinicians.

“From 2016 to 2021, the odds of prescribing buprenorphine among clinicians in the OCHIN Inc CHC network increased significantly… more than one-third of CHC clinicians prescribed buprenorphine in 2021,” authors of the study wrote. “The increase was...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Provider, Survey / Study, Trends
Behavioral health needs better metrics — Centerstone steps up
Wellpath's behavioral health unit becomes independent company
1 system's 'no wrong door' strategy for behavioral health
Prisma Health opens $3.7 million behavioral health facility
‘Not For the Faint of Heart’: What Makes (or Breaks) Mental Health Payer Pilots

Share This Article